BamSEC and AlphaSense Join Forces
Learn More

Lisata Therapeutics Inc. – Material Contracts

NASDAQ: LSTA    
Share price (3/27/26): $5.02    
Market cap (3/27/26): $45.3 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.19
from 10-K 36 pages Material contract
12/34/56
EX-10.18
from 10-K 53 pages David J. Mazzo, Phd President & CEO Mark Land CEO David J. Mazzo, Phd President & CEO Mark Land CEO
12/34/56
EX-10.5
from 10-K 38 pages Material contract
12/34/56
EX-10.2
from 10-K 18 pages Material contract
12/34/56
EX-10.1
from 8-K 3 pages [Signature Page to Amendment to Binding Term Sheet] in Witness Whereof, the Parties to This Amendment Have Caused Same to Be Executed as of the Date First Written Above. Lisata Therapeutics, Inc. By: Name: David J. Mazzo, PH.D. Title: President and CEO Kuva Labs Inc. By: Name: Mark Land Title: CEO
12/34/56
EX-10.4
from 10-Q 9 pages Material contract
12/34/56
EX-10.3
from 10-Q 9 pages Material contract
12/34/56
EX-10.2
from 10-Q 21 pages Material contract
12/34/56
EX-10.1
from 10-Q 16 pages Material contract
12/34/56
EX-10.4
from 8-K 9 pages Material contract
12/34/56
EX-10.3
from 8-K 9 pages Material contract
12/34/56
EX-10.2
from 8-K 21 pages Material contract
12/34/56
EX-10.1
from 8-K 16 pages Material contract
12/34/56
EX-10.14
from 10-K 53 pages David J. Mazzo, Phd President & CEO Mark Land CEO David J. Mazzo, Phd President & CEO Mark Land CEO
12/34/56
EX-10.5
from 10-K 38 pages Material contract
12/34/56
EX-10.2
from 10-K 103 pages Material contract
12/34/56
EX-10.5
from 10-K 30 pages Material contract
12/34/56
EX-10.2
from 10-K 86 pages Material contract
12/34/56
EX-10.1
from 10-Q 8 pages Material contract
12/34/56
EX-10.25
from 10-K 4 pages Lisata Therapeutics, Inc. Clawback Policy
12/34/56